Enrichment
NOVAVAX
NOVAVAX is a company.
FilterKey facts
- City: Gaithersburg
- State: MD
- Country: United States
- Sector: Health Care
- Foundation year: 1987
- Industry: Biotechnology
- CEO: Stanley Charles Erck
- Stack: Google Analytics
Latest news (see all)
Activist investor blasts Novavax for not using mRNA fears to boost COVID-19 vaccine sales
Read: Quartz
2024-04-15
Hedge fund urges board shake-up at Novavax over struggling Covid vaccine
Read: Financial Times
2024-04-15
Stocks making the biggest moves midday: Nvidia, Rivian, Moderna, Novavax and more
Read: CNBC News
2024-02-22
Novavax updated Covid vaccine wins FDA, CDC backing, paving way to reach Americans within days
Read: CNBC News
2023-10-03
Get ready for MORE booster Covid vaccines! Brand new shots made by Pfizer, Moderna and Novavax to be available in mid-September – but only 17% of Americans took the last one!
Read: BBC
2023-08-25
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
Read: CNBC News
2023-08-18
Metrics
General information
Business
| assets | 2.6B $ |
| Debt | 538.6M $ |
| free cash flow | -509,246,000.00 |
| market cap | 2,289,410,000.00 |
| profits | -1743750000 $ |
Visualizations
Datasets
Companies in the United States
Companies where Industry equals Biotechnology
Companies where Sector equals Health Care
Stocks for NOVAVAX
Source
This dashboard is based on data from: Twitter, YAHOO-FIN, YFINANCE
Updated: 2 days ago
License
This content can be used under the CC BY 4.0 license
